Autologous serum improves yield and metabolic capacity of monocyte-derived hepatocyte-like cells: Possible implication for cell transplantation

Cell Transplantation

Volumn 20, Issue 9, 2011, Pages 1465-1477

  Ehnert, S ^a   Seeliger, C ^a   Vester, H ^a   Schmitt, A ^a   Saidy Rad, S ^a   Lin, J ^a   Neumaier, M ^a   Gillen, S ^a   Kleeff, J ^a   Friess, H ^a   Burkhart, J ^b   Stockle U ^a   Nussler A K ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Blood Donor Service   (Germany)

Author keywords

Autologous cell therapy; Macrophage; Neohepatocytes; Primary human hepatocytes; Programmable cells of monocytic origin (PCMOs)

Indexed keywords

CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 3A4; GLUCOSE 6 PHOSPHATASE; GLUTATHIONE TRANSFERASE; MATRIX METALLOPROTEINASE; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL METABOLISM; CELL TRANSPLANTATION; CYTOKINE RELEASE; ENZYME ACTIVITY; FETAL CALF SERUM; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; LIVER CELL; MACROPHAGE ACTIVATION; MONOCYTE; NUCLEOTIDE SEQUENCE; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; SERUM; UREA CYCLE;

AMMONIUM CHLORIDE; CELL TRANSPLANTATION; GENE EXPRESSION REGULATION; GLUCOSE; HEPATOCYTES; HUMANS; INTERLEUKINS; MACROPHAGE ACTIVATION; MATRIX METALLOPROTEINASES; METABOLIC DETOXICATION, PHASE I; METABOLIC DETOXICATION, PHASE II; MONOCYTES; RANK LIGAND; RNA, MESSENGER; SERUM; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; UREA;

EID: 80855150903     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X550224     Document Type: Article

References (45)

1. Agarwal S., Holton K. L., Lanza R. Efficient differentiation of functional hepatocytes from human embryonic stem cells. Stem Cells 26(5):1117-1127, 2008.
2. Asahina K., Teramoto K., Teraoka H. Embryonic stem cells: Hepatic differentiation and regenerative medicine for the treatment of liver disease. Curr. Stem Cell Res. Ther. 1(2):139-156, 2006.
3. Aurich H., Sgodda M., Kaltwasser P., Vetter M., Weise A., Liehr T., Brulport M., Hengstler J. G., Dollinger M. M., Fleig W. E., Christ B. Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo. Gut 58(4):570-581, 2009.
4. Ayache S., Panelli M. C., Byrne K. M., Slezak S., Leitman S. F., Marincola F. M., Stroncek D. F. Comparison of proteomic profiles of serum, plasma, and modified media supplements used for cell culture and expansion. J. Transl. Med. 4:40, 2006.
5. Banas A., Teratani T., Yamamoto Y., Tokuhara M., Takeshita F., Quinn G., Okochi H., Ochiya T. Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology 46(1):219-228, 2007.
6. Bourgin-Hierle C., Gobert-Gosse S., Therier J., Grasset M. F., Mouchiroud G. Src-family kinases play an essential role in differentiation signaling downstream of macrophage colony-stimulating factor receptors mediating persistent phosphorylation of phospholipase C-gamma2 and MAP kinases ERK1 and ERK2. Leukemia 22(1):161-169, 2008.
7. Buzzeo M. P., Yang J., Casella G., Reddy V. A preliminary gene expression profile of acute graft-versus-host disease. Cell Transplant. 17(5):489-494, 2008.
8. Campard D., Lysy P. A., Najimi M., Sokal E. M. Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells. Gastroenterology 134(3):833-848, 2008.
9. Donato M. T., Lahoz A., Montero S., Bonora A., Pareja E., Mir J., Castell J. V., Gomez-Lechon M. J. Functional assessment of the quality of human hepatocyte preparations for cell transplantation. Cell Transplant. 17(10-11):1211-1219, 2008.
10. Dorrell C., Takenaka K., Minden M. D., Hawley R. G., Dick J. E. Hematopoietic cell fate and the initiation of leukemic properties in primitive primary human cells are influenced by Ras activity and farnesyltransferase inhibition. Mol. Cell. Biol. 24(16):6993-7002, 2004.
11. Duraisingham S. S., Hornig J., Gotch F., Patterson S. TLR-stimulated CD34 stem cell-derived human skin-like and monocyte-derived dendritic cells fail to induce Th17 polarization of naive T cells but do stimulate Th1 and Th17 memory responses. J. Immunol. 183(4):2242-2251, 2009.
12. Ehnert S., Glanemann M., Schmitt A., Vogt S., Shanny N., Nussler N. C., Stockle U., Nussler A. The possible use of stem cells in regenerative medicine: Dream or reality? Langenbecks Arch. Surg. 394(6):985-997, 2009.
13. Ehnert S., Knobeloch D., Blankenstein A., Muller A., Bocker U., Gillen S., Friess H., Thasler W. E., Dooley S., Nussler A. K. Neohepatocytes from alcoholics and controls express hepatocyte markers and display reduced fibrogenic TGF-beta/Smad3 signaling: Advantage for cell transplantation? Alcohol. Clin. Exp. Res. 34(4):708-718, 2010.
14. Ehnert S., Nussler A. K., Lehmann A., Dooley S. Blood monocyte-derived neohepatocytes as in vitro test system for drug metabolism. Drug Metab. Dispos. 36(9):1922-1929, 2008.
15. Gai H., Nguyen D. M., Moon Y. J., Aguila J. R., Fink L. M., Ward D. C., Ma Y. Generation of murine hepatic lineage cells from induced pluripotent stem cells. Differentiation 79(3):171-181, 2010.
16. Glanemann M., Gaebelein G., Nussler N., Hao L., Kronbach Z., Shi B., Neuhaus P., Nussler A. K. Transplantation of monocyte-derived hepatocyte-like cells (NeoHeps) improves survival in a model of acute liver failure. Ann. Surg. 249(1):149-154, 2009.
17. Gobert Gosse S., Bourgin C., Liu W. Q., Garbay C., Mouchiroud G. M-CSF stimulated differentiation requires persistent MEK activity and MAPK phosphorylation independent of Grb2-Sos association and phosphatidylinositol 3-kinase activity. Cell. Signal. 17(11):1352-1362, 2005.
18. Grasset M. F., Gobert-Gosse S., Mouchiroud G., Bourette R. P. Macrophage differentiation of myeloid progenitor cells in response to M-CSF is regulated by the dual-specificity phosphatase DUSP5. J. Leukoc. Biol. 87(1):127-135, 2010.
19. Habibullah C. M., Syed I. H., Qamar A., Taher-Uz Z. Human fetal hepatocyte transplantation in patients with fulminant hepatic failure. Transplantation 58(8):951-952, 1994.
20. Jack G. D., Zhang L., Friedman A. D. M-CSF elevates c-Fos and phospho-C/EBPalpha(S21) via ERK whereas G-CSF stimulates SHP2 phosphorylation in marrow progenitors to contribute to myeloid lineage specification. Blood 114(10):2172-2180, 2009.
21. Jones E. A., Tosh D., Wilson D. I., Lindsay S., Forrester L. M. Hepatic differentiation of murine embryonic stem cells. Exp. Cell Res. 272(1):15-22, 2002.
22. Jung D., Biggs H., Erikson J., Ledyard P. U. New colorimetric reaction for end-point, continuous-flow, and kinetic measurement of urea. Clin. Chem. 21(8):1136-1140, 1975.
23. Lehec S. C., Hughes R. D., Mitry R. R., Graver M. A., Verma A., Wade J. J., Dhawan A. Experience of microbiological screening of human hepatocytes for clinical transplantation. Cell Transplant. 18(8):941-947, 2009.
24. Li W., Wang D., Qin J., Liu C., Zhang Q., Zhang X., Yu X., Lahn B. T., Mao F. F., Xiang A. P. Generation of functional hepatocytes from mouse induced pluripotent stem cells. J. Cell. Physiol. 222(3):492-501, 2010.
25. Lysy P. A., Campard D., Smets F., Najimi M., Sokal E. M. Stem cells for liver tissue repair: Current knowledge and perspectives. World J. Gastroenterol. 14(6):864-875, 2008.
26. Lysy P. A., Smets F., Sibille C., Najimi M., Sokal E. M. Human skin fibroblasts: From mesodermal to hepatocyte-like differentiation. Hepatology 46(5):1574-1585, 2007.
27. Mito M., Kusano M., Kawaura Y. Hepatocyte transplantation in man. Transplant. Proc. 24(6):3052-3053, 1992.
28. Miyazaki M., Hardjo M., Masaka T., Tomiyama K., Mahmut N., Medina R. J., Niida A., Sonegawa H., Du G., Yong R., Takaishi M., Sakaguchi M., Huh N. H. Isolation of a bone marrow-derived stem cell line with high proliferation potential and its application for preventing acute fatal liver failure. Stem Cells 25(11):2855-2863, 2007.
29. Mizuguchi T., Mitaka T., Katsuramaki T., Hirata K. Hepatocyte transplantation for total liver repopulation. J. Hepatobiliary Pancreat. Surg. 12(5):378-385, 2005.
30. Najimi M., Khuu D. N., Lysy P. A., Jazouli N., Abarca J., Sempoux C., Sokal E. M. Adult-derived human liver mesenchymal-like cells as a potential progenitor reservoir of hepatocytes? Cell Transplant. 16(7):717-728, 2007.
31. Nussler A., Konig S., Ott M., Sokal E., Christ B., Thasler W., Brulport M., Gabelein G., Schormann W., Schulze M., Ellis E., Kraemer M., Nocken F., Fleig W., Manns M., Strom S. C., Hengstler J. G. Present status and perspectives of cell-based therapies for liver diseases. J. Hepatol. 45(1):144-159, 2006.
32. Ott M., Schmidt H. H., Cichon G., Manns M. P. Emerging therapies in hepatology: Liver-directed gene transfer and hepatocyte transplantation. Cells Tissues Organs 167(2-3):81-87, 2000.
33. Puppi J., Dhawan A. Human hepatocyte transplantation overview. Methods Mol. Biol. 481:1-16, 2009.
34. Quaglia A., Lehec S. C., Hughes R. D., Mitry R. R., Knisely A. S., Devereaux S., Richards J., Rela M., Heaton N. D., Portmann B. C., Dhawan A. Liver after hepatocyte transplantation for liver-based metabolic disorders in children. Cell Transplant. 17(12):1403-1414, 2008.
35. Quintanilha L. F., Mannheimer E. G., Carvalho A. B., Paredes B. D., Dias J. V., Almeida A. S., Gutfilen B., Barbosa da Fonseca L. M., Resende C. M., Rezende G. F., Campos de Carvalho A. C., Goldenberg R. C. Bone marrow cell transplant does not prevent or reverse murine liver cirrhosis. Cell Transplant. 17(8):943-953, 2008.
36. Ruhnke M., Ungefroren H., Nussler A., Martin F., Brulport M., Schormann W., Hengstler J. G., Klapper W., Ulrichs K., Hutchinson J. A., Soria B., Parwaresch R. M., Heeckt P., Kremer B., Fandrich F. Differentiation of in vitro-modified human peripheral blood monocytes into hepatocyte-like and pancreatic islet-like cells. Gastroenterology 128(7):1774-1786, 2005.
37. Sancho-Bru P., Najimi M., Caruso M., Pauwelyn K., Cantz T., Forbes S., Roskams T., Ott M., Gehling U., Sokal E., Verfaillie C. M., Muraca M. Stem and progenitor cells for liver repopulation: Can we standardise the process from bench to bedside? Gut 58(4):594-603, 2009.
38. Sokal E. M., Smets F., Bourgois A., Van Maldergem L., Buts J. P., Reding R., Bernard Otte J., Evrard V., Latinne D., Vincent M. F., Moser A., Soriano H. E. Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: Technique, safety, and metabolic follow-up. Transplantation 76(4):735-738, 2003.
39. Strom S., Fisher R. Hepatocyte transplantation: New possibilities for therapy. Gastroenterology 124(2):568-571, 2003.
40. Strom S. C., Bruzzone P., Cai H., Ellis E., Lehmann T., Mitamura K., Miki T. Hepatocyte transplantation: Clinical experience and potential for future use. Cell Transplant. 15(Suppl. 1):S105-110, 2006.
41. Sumitran-Holgersson S., Nowak G., Thowfeequ S., Begum S., Joshi M., Jaksch M., Kjaeldgaard A., Jorns C., Ericzon B. G., Tosh D. Generation of hepatocyte-like cells from in vitro transdifferentiated human fetal pancreas. Cell Transplant. 18(2):183-193, 2009.
42. Tesseur I., Zou K., Berber E., Zhang H., Wyss-Coray T. Highly sensitive and specific bioassay for measuring bioactive TGF-beta. BMC Cell Biol. 7:15, 2006.
43. Tosh D., Shen C. N., Slack J. M. Differentiated properties of hepatocytes induced from pancreatic cells. Hepatology 36(3):534-543, 2002.
44. Tsuruga Y., Kiyono T., Matsushita M., Takahashi T., Kasai H., Matsumoto S., Todo S. Establishment of immortalized human hepatocytes by introduction of HPV16 E6/E7 and hTERT as cell sources for liver cell-based therapy. Cell Transplant. 17(9):1083-1094, 2008.
45. Zemel R., Bachmetov L., Ad-El D., Abraham A., Tur-Kaspa R. Expression of liver-specific markers in naive adipose-derived mesenchymal stem cells. Liver Int. 29(9):1326-1337, 2009.